Single Agent Activity Of U3-1402, A Her3-Argeting Antibody-Drug Conjugate, In Breast Cancer Patients: Phase 1 Dose Escalation Study.
Takahiro Kogawa,Kan Yonemori,Norikazu Masuda,Shunji Takahashi,Masato Takahashi,Hirotaka Iwase,Takahiro Nakayama,Toshiaki Saeki,Tatsuya Toyama,Toshimi Takano,Hiroshi Onuma,Hayao Ogawa,Yoshimi Tanaka, Yoshiko Igari,Masahiro Sugihara,Michele Vigliotti,Channing Yu, Martin Sebastian Olivo,Suguru Ueno,Hiroji Iwata JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
